Melanoma is a type of skin
cancer that occurs when pigment-producing cells become malignant. It is a
particularly dangerous form of skin cancer because it can spread to other parts
of the body if not detected and treated early.
A study conducted by the
University of Eastern Finland and Kuopio University Hospital found that fewer
cases of melanoma were observed among regular users of vitamin D supplements.
Experienced dermatologists also estimated that those taking vitamin D supplements
regularly had a significantly lower skin cancer risk. The study, published in
Melanoma Research, involved nearly 500 individuals at elevated risk for skin
cancer and showed that those who took vitamin D supplements regularly had a
reduced incidence of melanoma compared to non-users.
The function of Vitamin D:
Vitamin D is vital for the proper functioning of the human body and may be implicated in various diseases. There has been extensive research on the relationship between vitamin D and skin cancers, with a focus on calcidiol, a metabolite of vitamin D, and its correlation with skin cancers. Previous studies have centered on examining serum levels of calcidiol and its link to skin cancers.
Findings:
Findings from these studies
have been inconclusive and even contradictory at times, as serum calcidiol
levels have been associated with both a slightly higher and a slightly lower
risk of different skin cancers. This may partly be explained by the fact that
serum calcidiol analyses do not provide information on the metabolism of vitamin
D in the human skin, which can express enzymes that generate biologically
active vitamin D metabolites or inactivate them.
Skin Cancer:
The new study, conducted under
the North Savo Skin Cancer Programmed, took a different approach: 498 adult
patients estimated to have an increased risk of skin cancer, such as basal cell
carcinoma, squamous cell carcinoma, or melanoma, were recruited at the
dermatological outpatient clinic of Kuopio University Hospital. Experienced
dermatologists at the University of Eastern Finland carefully analyzed the
patients’ background information and medical history and examined their skin.
Dermatologists:
The dermatologists also classified the patients into different skin cancer risk classes: low risk, moderate risk, and high risk. Based on their use of oral vitamin D supplements, the patients were divided into three groups: non-users, occasional users, and regular users. Serum calcidiol levels were analyzed in half of the patients and found to correspond to their self-reported use of vitamin D.
A key finding of the study is that there were considerably fewer cases of melanoma among regular users of vitamin D than among non-users and that the skin cancer risk classification of regular users was considerably better than non-users. Logistic regression analysis showed that the risk for melanoma among regular users was considerably reduced, more than halved, compared to non-users.
The findings suggest that even occasional users of vitamin D may have a lower risk for melanoma than non-users. However, there was no statistically significant association between the use of vitamin D and the severity of photoaging, facial photoaging, actinic keratoses, nevus count, basal cell carcinoma, and squamous cell carcinoma. Serum calcidiol levels were not significantly associated with these skin changes, either. Since the research design was cross-sectional, the researchers were unable to demonstrate a causal relationship.
Melanoma:
Other relatively recent studies, too, have provided evidence of the benefits of vitamin D in melanoma, such as the association of vitamin D with less aggressive melanoma.
“These earlier studies back our new findings from the North Savo region here in Finland. However, the question about the optimal dose of oral vitamin D for its beneficial effects remains to be answered. Until we know more, national intake recommendations should be followed,” Professor of Dermatology and Allergology Ilkka Harvima of the University of Eastern Finland notes.
Conclusion:
From above, it concluded that
Vitamin D supplementation does not lower the risk of skin cancer. While
adequate vitamin D levels are important for overall health, taking large
amounts of vitamin D supplements is not a proven method for preventing skin
cancer. In fact, excessive sun exposure, a major source of vitamin D, increases
the risk of skin cancer. It's best to get vitamin D from a balanced diet and
limited sun exposure rather than relying on supplements. Vitamin D
supplementation does not reduce the risk of skin cancer. While vitamin D is
important for overall health and can help prevent other types of cancer, there
is no evidence that it reduces the risk of skin cancer. In fact, excessive sun
exposure, a major source of vitamin D, increases the risk of skin cancer.